Heather L. Davis

13.7k total citations · 2 hit papers
141 papers, 10.9k citations indexed

About

Heather L. Davis is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Heather L. Davis has authored 141 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Immunology, 58 papers in Epidemiology and 50 papers in Molecular Biology. Recurrent topics in Heather L. Davis's work include Immunotherapy and Immune Responses (64 papers), Immune Response and Inflammation (46 papers) and Hepatitis B Virus Studies (38 papers). Heather L. Davis is often cited by papers focused on Immunotherapy and Immune Responses (64 papers), Immune Response and Inflammation (46 papers) and Hepatitis B Virus Studies (38 papers). Heather L. Davis collaborates with scholars based in Canada, United States and France. Heather L. Davis's co-authors include Michael J. McCluskie, Arthur Μ. Krieg, Risini D. Weeratna, Robert G. Whalen, Joachim Schorr, Barbara Demeneix, Paul Payette, Susan M. Efler, Cynthia L. Brazolot Millan and Marie-Louise Michel and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Heather L. Davis

137 papers receiving 10.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CpG DNA Is a Potent Enhancer of Specific Immunity in Mice Immunized with Recombinant Hepatitis B Surface Antigen

1998 596 citations Heather L. Davis, Joachim Schorr et al. The Journal of Immunology profile →
Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo

2000 507 citations Gunther Hartmann, Risini D. Weeratna et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heather L. Davis Canada	54	6.7k	3.5k	3.2k	1.6k	922	141	10.9k
Lena Alexopoulou France	50	13.2k 2.0×	3.8k 1.1×	3.7k 1.2×	2.0k 1.3×	891 1.0×	76	18.0k
Søren R. Paludan Denmark	64	9.1k 1.4×	5.0k 1.4×	3.9k 1.2×	2.7k 1.7×	315 0.3×	169	14.2k
Jeffrey B. Ulmer United States	55	7.0k 1.0×	5.7k 1.6×	3.7k 1.2×	4.1k 2.5×	494 0.5×	143	13.2k
Grayson B. Lipford Germany	42	9.4k 1.4×	3.3k 0.9×	2.1k 0.6×	1.0k 0.6×	1.2k 1.3×	70	12.0k
Barry T. Rouse United States	73	10.1k 1.5×	3.0k 0.9×	7.4k 2.3×	1.8k 1.2×	365 0.4×	377	17.5k
Bernhard Fleischer Germany	59	5.2k 0.8×	1.9k 0.6×	2.8k 0.9×	2.5k 1.5×	391 0.4×	299	12.0k
Dennis M. Klinman United States	75	15.8k 2.4×	7.1k 2.0×	3.8k 1.2×	2.6k 1.6×	1.8k 1.9×	283	23.1k
Hiroaki Hemmi Japan	45	21.3k 3.2×	6.6k 1.9×	4.6k 1.5×	2.1k 1.3×	1.9k 2.0×	82	27.2k
David Masopust United States	64	17.3k 2.6×	2.9k 0.8×	3.1k 1.0×	2.1k 1.3×	250 0.3×	127	21.5k
Thomas M. Kündig Switzerland	64	11.0k 1.6×	3.7k 1.0×	1.9k 0.6×	1.2k 0.7×	235 0.3×	226	18.0k

Countries citing papers authored by Heather L. Davis

Since Specialization

Citations

This map shows the geographic impact of Heather L. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather L. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather L. Davis more than expected).

Fields of papers citing papers by Heather L. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather L. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather L. Davis. The network helps show where Heather L. Davis may publish in the future.

Co-authorship network of co-authors of Heather L. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Heather L. Davis. A scholar is included among the top collaborators of Heather L. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather L. Davis. Heather L. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mak, Lung‐Yi, Christine I. Wooddell, Oliver Lenz, et al.. (2024). Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989. Gut. 74(3). 440–450. 17 indexed citations

Weeratna, Risini D., Ghania Chikh, Lu Zhang, et al.. (2016). Immunogenicity of a peptide‐based anti‐IgE conjugate vaccine in non‐human primates. Immunity Inflammation and Disease. 4(2). 135–147. 7 indexed citations

McCluskie, Michael J., David C. Pryde, David Gervais, et al.. (2013). Enhancing immunogenicity of a 3′aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates. International Immunopharmacology. 16(1). 50–56. 42 indexed citations

McCluskie, Michael J., Risini D. Weeratna, Paul Payette, & Heather L. Davis. (2002). Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. FEMS Immunology & Medical Microbiology. 32(3). 179–185. 76 indexed citations

Weeratna, Risini D., Cynthia L. Brazolot Millan, Michael J. McCluskie, & Heather L. Davis. (2001). CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice. FEMS Immunology & Medical Microbiology. 32(1). 65–71. 81 indexed citations

Ballas, Zuhair K., Arthur Μ. Krieg, Thomas L. Warren, et al.. (2001). Divergent Therapeutic and Immunologic Effects of Oligodeoxynucleotides with Distinct CpG Motifs. The Journal of Immunology. 167(9). 4878–4886. 220 indexed citations

Gallichan, W. Scott, et al.. (2001). Intranasal Immunization with CpG Oligodeoxynucleotides as an Adjuvant Dramatically Increases IgA and Protection Against Herpes Simplex Virus-2 in the Genital Tract. The Journal of Immunology. 166(5). 3451–3457. 186 indexed citations

Weeratna, Risini D., Cynthia L. Brazolot Millan, Michael J. McCluskie, Claire‐Anne Siegrist, & Heather L. Davis. (2001). Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies. FEMS Immunology & Medical Microbiology. 30(3). 241–247. 33 indexed citations

Weeratna, Risini D., et al.. (2001). The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants. Vaccine. 19(17-19). 2657–2660. 43 indexed citations

10.

Hartmann, Gunther, Risini D. Weeratna, Zuhair K. Ballas, et al.. (2000). Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo. The Journal of Immunology. 164(3). 1617–1624. 507 indexed citations breakdown →

11.

McCluskie, Michael J., Risini D. Weeratna, Arthur Μ. Krieg, & Heather L. Davis. (2000). CpG DNA is an effective oral adjuvant to protein antigens in mice. Vaccine. 19(7-8). 950–957. 87 indexed citations

12.

McCluskie, Michael J., Risini D. Weeratna, & Heather L. Davis. (2000). The role of CpG in DNA vaccines. Springer Seminars in Immunopathology. 22(1-2). 125–132. 39 indexed citations

13.

McCluskie, Michael J., Cynthia L. Brazolot Millan, Robert Gramzinski, et al.. (1999). Route and Method of Delivery of DNA Vaccine Influence Immune Responses in Mice and Non-Human Primates. Molecular Medicine. 5(5). 287–300. 149 indexed citations

14.

McCluskie, Michael J., et al.. (1998). Immunization Against Hepatitis B Virus by Mucosal Administration of Antigen–Antibody Complexes. Viral Immunology. 11(4). 245–252. 27 indexed citations

15.

Michel, Marie‐Laure, et al.. (1998). DNA immunization to hepatitis B surface antigen [HBsAg] as an approach to prevention and therapy for hepatitis B. Bulletin of the Veterinary Institute in Pulawy. 42(1). 1 indexed citations

16.

Heppell, Joël, Niels Lorenzen, Tong Wu, et al.. (1998). Development of DNA vaccines for fish: vector design, intramuscular injection and antigen expression using viral haemorrhagic septicaemia virus genes as model. Fish & Shellfish Immunology. 8(4). 271–286. 111 indexed citations

17.

Davis, Heather L.. (1996). DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine. 14(9). 910–915. 131 indexed citations

18.

Davis, Heather L., Marie-Louise Michel, & Robert G. Whalen. (1993). DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Human Molecular Genetics. 2(11). 1847–1851. 345 indexed citations

19.

Davis, Heather L., et al.. (1988). Myotrophic effects on denervated fast-twitch muscles of mice: Correlation of physiologic, biochemical, and morphologic findings. Experimental Neurology. 99(2). 474–489. 8 indexed citations

20.

Davis, Heather L.. (1987). Sciatic nerve protein composition in normal and dystrophic C57BL/6J mice. Neuroscience Letters. 75(1). 95–100. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact